{"ticker": {"uuid": "1fb145eb-ecf0-437d-aca4-b7a6e873807b", "symbol": "LKFT", "name": "Lakefront Biotherapeutics NV", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPT3lNZWpzWlNpTjVoWDB2WXR5cURWR1dFZnlsZnRNZ2ZFN1JfZXFpMm9oZ0Rqem1zbDRRa2ZZdGpHYWZWQlZrNE10NmY3RWxGSFo5amctbF9XaVRxejlibUlNelFtSkFTd1VELXd5MHVYWHN1OWNhcndlNHo3V2x5aXlOZmFCeWh4Z2pqQ3JQaVBaeXRnSVNPNTZrVVZJYUxwaEcwM01yVzktTHo2RzRLcG5maUhLVWYyOEltRE9UNHZNX3p0T0hlS3JOTWRLd2J5TGtmQl9HV0VmY3Y5anBDNkxXQXdoNGlabUZ0d3J6V2pNRmZ4am9STNIB_gFBVV95cUxNbVpxanlkeElGT3ZxZ3pTT21ZUHRBb204VVVmcU04MDZpckpFSWk3anFmWlJzbUx3S3lPN1FaN096QlMyUnhwV1piUjkwWFRIUks2T2s2enRWMFJ6bjZoLTU2dHB3eFVTcmtFdUZWYTN5UVhpTWlLb1dCZ1NIbW1teW1mYnMwek0zc3V1MlE1d2xZMk9Xbk12QVB2Q3BJRURVOGJrLUg2VWdKZzJqemx6cjljTk5CdDdqbFJuNDhLRzh6ZnpjYWd6OGR1bVYzWThaa2FFN0pjWFZKWDdqdVlaeElEa19XUi1xTHZ3b29xb3dhaWc4YkxnRENQUTJmZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T04:18:54+00:00", "published_display": "14 Jul 2026 04:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQb3BVOUhjb3FCWjFhYXYzWTYwMzNzUEQyckFwdzFJYjJsQzlxQTdUUlNHaWVxakdMcW41RWFzeEMxWHlKdWdLSmNjdFVrNnMybmpSNU5ZRjdrYmRocW9lUmZaMk92c0xhNUdKMjRkMUxqVUJrRTlJUGp4aHNma1JQbnBxZlRtcUgtcHlRd3NYbjFTOXp0dDlzaU1GbXVKMmszMndHWHVTZ005WTNYU1NoZ3UxVzRCcVN6MkZpQ2ZCTllxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:33:06+00:00", "published_display": "13 Jul 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQVZCRG5DQ3NBaDVueThyUFppX0FmbGZ4UndFNmJMdDZyZkxsQ0MxZjBvZVBlVlVvOVM3TW9zVTlNazdQV0VOLUpLZTh2X09QUXlNOVZvZm9mTE05Ukg4UGYxeFpWV3cweHBBd1JfZWI0NVUyRkliNFd6UFpxY2dnbVFtS2NudlVGOTdNMFgwNk9TOHdUMXVGekRRNXY3LVZoUWFXY0JtTG5SUFVZc2pOaUt1MzUzZUR2d3pVM25DNzR6VzBjamZKMGw0UUNIc1NzbEVTTFhoVFhnekxuVzZuVFpXQ25xcy1i?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T20:01:04+00:00", "published_display": "13 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stanley with $30 Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcUF5TmtvYXBsN0hZR3ZZRTREQ09NR21UZVRMRWZxVGE5RHczZ0VQQVdrV01XcHBVRk5JX3ZhTXplVkxVOXZIR1ROdmFKcHhYbnJwbUNSYlpsajVVSWU3QUdobzNDMWVibDZaY2huTG81ZXBUVXhqYVNwUjB5Z3pUdkNqekpXU2FkTjI1emRkLXNUa1NEOU1KM19TalpnSWVhSXNOM2x0OGg2TEtIZUVlZURGRDYtRWZyUlpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T17:33:01+00:00", "published_display": "10 Jul 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPTThhT01fZC12Mmw2cDE4SmlIMFRBbF9ibTc3Um1uNlVLTFhUZWp4SjdSQUNKQ29NWVJzS1poSHJsWEFkNHV5MEQ2OUpFbWNMYi1hMDk2NGlEdlRoMTRCSlRIbXkzSDZBNkY1dmlSU3B4eEtIcmFhalNjNW9YUlVELWdTTEtNdVpPUllNb0pHR212Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T16:41:27+00:00", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQd3VvdW1TamdEaGRTUFZrRE02Q21ISy1HTlFCbWNWRFBIOC1LRTYwV2o0MW5uc1BCblVRdU14dG1tYlB0RWhmX05rd293ZHJTOWhGUEZHOHJ3V1p6QldnVENnOFpXNU81WlFJUWZSV3IxS0EwQWRPV2wtejc2VmlfRkdjNjUxcTQ1bjFXMW1IRW0tUDNNbHZaMW11UDdSakk0SFJULWd0Y1BEV2t3cEVyZDRhajM3ZWJBRzN6UHNFQ09SbnJnVFlNMTQ2TENvVTNJSDdMZWJmeEQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-10T07:34:09+00:00", "published_display": "10 Jul 2026 07:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madison Avenue lifts Lakefront (NASDAQ: LKFT) ownership above 5% level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOWWJ3VzAzam1BeDl0dm5Xbnh4WDIzWWxlR09GVDdWbmpoU09WQ3ZBNFR5M2RvMHVIYlBTdHVDODAwN0JEYjJ3NFk2NmNMMTBPTTNlSkJYZ1IzTnpXYUV2VmJZOHZoSkNCV3A5cmZOdlRQU2ZHcFpFMktGMkpCS3luRWhNeWpnbHlPVFdNVDJYSlNZSjB5LWtNZk1wMTVnaXZUM1pWenFyemRBQ0pjR25SS0hKNEk5Z1J5a2lwdWRkaHlFZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Receives Transparency Notification from Madison Avenue Partners", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lakefront-receives-transparency-notification-madison-200100624.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T20:01:00+00:00", "published_display": "29 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUEhYMWZXel82M2ViVEpCT3lkTFpHUFJmMU56ZmI0bUhER1ZQX21obGZSc3dMVE4wdkRUSTJISktBZ1JIbGN1TE5LRGEwN2ZMRjF5WTJNbzNWOXVRbDYydXo4OUxBWmFQa3l4YjFGdGxwdThMQWZBTFRyTnd1VTlGM1JCcHdBOC03eTQ5ZTZEVl9lR2lKLUV2Q05DMW04b1R2TXotczF1TjlXQnlaVV9J?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics (ENXTAM:LKFT) Stock After Recent Gains Still A Recovery Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOUTV2Xy1oVUI4S1M5ckxKcktULUg2QzFITHZCUVF3dnlfN0k3TzIxRl81cDZoUThMb3BhSXYzZHRNNDRubzBxVWpSbXVGMGpVd0pGM3A5Q0ZmMzJJNWp4b2k5elUwc2E3MUNmcFJVLWJBLVRfdVpNYVdFWmthQ21YLW9GcVR4bFY4YnRpMXZTaXZ6Rm5xUFZTTDhmNEo0WHJZcnEyX2lSRjVwcklW?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics Launches 50 Million Euros Share Repurchase Program", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lakefront-biotherapeutics-launches-50-million-201816407.html", "source_name": "MT Newswires", "published_at": "2026-06-09T20:18:16+00:00", "published_display": "09 Jun 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Initiation of \u20ac50 Million Stock Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOQ3c5UVZ2bzhFOVYwZlpSdVJUZ3RjMWJrZHFSY045X0ZUek1yNXh1LWxzcG9yYXdsX0lCc1h5bi0yd045MnNkTlJfaDR5THEweGZNeWdIckJ3clJsOE1MMkFjODBEVVNpT3dpR24yc3dXOWhyZ0JNUFc0Y0VmXzJFcG55WjJZVXpfTGE0YmZpbjY3eTFy?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics Names Eric Hedrick as Chief Medical Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lakefront-biotherapeutics-names-eric-hedrick-201939898.html", "source_name": "MT Newswires", "published_at": "2026-06-08T20:19:39+00:00", "published_display": "08 Jun 2026 20:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lakefront-appoints-eric-hedrick-md-200100378.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T20:01:00+00:00", "published_display": "08 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gilead-sciences-gild-lakefront-biotherapeutics-043916213.html", "source_name": "Insider Monkey", "published_at": "2026-06-07T04:39:16+00:00", "published_display": "07 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPaklHUjVLbE9BTFJkalhwcUdXMnY4aXk2c0d2dU1vSTNjbDlXRnJwYzVIcmxwazRjemxDUVNVQ2VJLWNDTU1haTFRMi1kbE5KSGV5QUFpSjJKbkZOSTlwU1JEOW13SFNTODYzVVJyNS1SSGlhbVlSOFNLc2VKM3dTUk9HVmwzbDZNTHN6dUxFMUhLWDRPS2szSUswcVBneXZm?oc=5", "source_name": "grafa.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Lakefront Complete Ouro Medicines Acquisition", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gilead-sciences-lakefront-complete-ouro-204127804.html", "source_name": "MT Newswires", "published_at": "2026-06-04T20:41:27+00:00", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Receives Transparency Notification from Bank of America", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPRnhFbzZycGxWYl9GVGR2bUlmYTNOV3ZZYlptVnBtd3pQYTdkOTBJRUY1a3VWbHdWRUdkYW9JekVLaE9tQ3ZFOW9ReUYzZlRJU3ZHZGdVNU1uaWY4azFMcWZucmRHRFgzcnBrbUlZWnBYeXk4OGJmcW5MZzctWXo4S1pPRUVPal83RXZ3UkNXcUYzWEFNQWdRcEM3aGd1Nkd3UUhJbGE1MkxfTVc1QTlaSUtfdTc?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Report: Lakefront Biotherapeutics NV Missed Revenue Estimates By 78%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9qdDdJT05vRTNrWVhnMmozbE5QajNMdGVFWTM5Y0wwNWVpWUt3VHRFSUxONmFRRE00X004eF95WEI5dmJmcXExc1V0RC14bExUUWZnV1pCNHpoQUJmcG1QN2F3NkczQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-10T05:12:57+00:00", "published_display": "10 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV (AMS:LKFT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQUk1TGNXbHl3WEY1MF90VkVLRnE2anN2M3dNQzQ4V2JHRTlYTDlJaWpUUDZVSnVDYW1sTW04V2dVc3VfV25QbXZmdmlOd3NXdTEwelMxZDRCRENub3V6VXdxb1M3bGFPZVFPcHhkN2FNSzFLMGFQSjd0X2IzNU1SUDMtR0gxQkluUUpXSWdyVlZjRU9BenN0UDlpdEtPV1F1NU93YjI4eS0zdw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LKFT Stock Price and Chart \u2014 NASDAQ:LKFT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1DV0pIQllMMTI0czlPUnBmMkRZV3EzZWxRcHZhcDdSRjl3dGhoSG55MmMxWjhfQWpXd1RtMHhNNTlxSGE3LTdTdlNkTVl3bHZrNDhyNFk3cHNjcTZJ?oc=5", "source_name": "TradingView", "published_at": "2026-05-08T11:48:31+00:00", "published_display": "08 May 2026 11:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxPT3lNZWpzWlNpTjVoWDB2WXR5cURWR1dFZnlsZnRNZ2ZFN1JfZXFpMm9oZ0Rqem1zbDRRa2ZZdGpHYWZWQlZrNE10NmY3RWxGSFo5amctbF9XaVRxejlibUlNelFtSkFTd1VELXd5MHVYWHN1OWNhcndlNHo3V2x5aXlOZmFCeWh4Z2pqQ3JQaVBaeXRnSVNPNTZrVVZJYUxwaEcwM01yVzktTHo2RzRLcG5maUhLVWYyOEltRE9UNHZNX3p0T0hlS3JOTWRLd2J5TGtmQl9HV0VmY3Y5anBDNkxXQXdoNGlabUZ0d3J6V2pNRmZ4am9STNIB_gFBVV95cUxNbVpxanlkeElGT3ZxZ3pTT21ZUHRBb204VVVmcU04MDZpckpFSWk3anFmWlJzbUx3S3lPN1FaN096QlMyUnhwV1piUjkwWFRIUks2T2s2enRWMFJ6bjZoLTU2dHB3eFVTcmtFdUZWYTN5UVhpTWlLb1dCZ1NIbW1teW1mYnMwek0zc3V1MlE1d2xZMk9Xbk12QVB2Q3BJRURVOGJrLUg2VWdKZzJqemx6cjljTk5CdDdqbFJuNDhLRzh6ZnpjYWd6OGR1bVYzWThaa2FFN0pjWFZKWDdqdVlaeElEa19XUi1xTHZ3b29xb3dhaWc4YkxnRENQUTJmZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T04:18:54+00:00", "published_display": "14 Jul 2026 04:18", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQb3BVOUhjb3FCWjFhYXYzWTYwMzNzUEQyckFwdzFJYjJsQzlxQTdUUlNHaWVxakdMcW41RWFzeEMxWHlKdWdLSmNjdFVrNnMybmpSNU5ZRjdrYmRocW9lUmZaMk92c0xhNUdKMjRkMUxqVUJrRTlJUGp4aHNma1JQbnBxZlRtcUgtcHlRd3NYbjFTOXp0dDlzaU1GbXVKMmszMndHWHVTZ005WTNYU1NoZ3UxVzRCcVN6MkZpQ2ZCTllxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:33:06+00:00", "published_display": "13 Jul 2026 20:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQVZCRG5DQ3NBaDVueThyUFppX0FmbGZ4UndFNmJMdDZyZkxsQ0MxZjBvZVBlVlVvOVM3TW9zVTlNazdQV0VOLUpLZTh2X09QUXlNOVZvZm9mTE05Ukg4UGYxeFpWV3cweHBBd1JfZWI0NVUyRkliNFd6UFpxY2dnbVFtS2NudlVGOTdNMFgwNk9TOHdUMXVGekRRNXY3LVZoUWFXY0JtTG5SUFVZc2pOaUt1MzUzZUR2d3pVM25DNzR6VzBjamZKMGw0UUNIc1NzbEVTTFhoVFhnekxuVzZuVFpXQ25xcy1i?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-13T20:01:04+00:00", "published_display": "13 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stanley with $30 Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcUF5TmtvYXBsN0hZR3ZZRTREQ09NR21UZVRMRWZxVGE5RHczZ0VQQVdrV01XcHBVRk5JX3ZhTXplVkxVOXZIR1ROdmFKcHhYbnJwbUNSYlpsajVVSWU3QUdobzNDMWVibDZaY2huTG81ZXBUVXhqYVNwUjB5Z3pUdkNqekpXU2FkTjI1emRkLXNUa1NEOU1KM19TalpnSWVhSXNOM2x0OGg2TEtIZUVlZURGRDYtRWZyUlpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-10T17:33:01+00:00", "published_display": "10 Jul 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPTThhT01fZC12Mmw2cDE4SmlIMFRBbF9ibTc3Um1uNlVLTFhUZWp4SjdSQUNKQ29NWVJzS1poSHJsWEFkNHV5MEQ2OUpFbWNMYi1hMDk2NGlEdlRoMTRCSlRIbXkzSDZBNkY1dmlSU3B4eEtIcmFhalNjNW9YUlVELWdTTEtNdVpPUllNb0pHR212Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-10T16:41:27+00:00", "published_display": "10 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQd3VvdW1TamdEaGRTUFZrRE02Q21ISy1HTlFCbWNWRFBIOC1LRTYwV2o0MW5uc1BCblVRdU14dG1tYlB0RWhmX05rd293ZHJTOWhGUEZHOHJ3V1p6QldnVENnOFpXNU81WlFJUWZSV3IxS0EwQWRPV2wtejc2VmlfRkdjNjUxcTQ1bjFXMW1IRW0tUDNNbHZaMW11UDdSakk0SFJULWd0Y1BEV2t3cEVyZDRhajM3ZWJBRzN6UHNFQ09SbnJnVFlNMTQ2TENvVTNJSDdMZWJmeEQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-10T07:34:09+00:00", "published_display": "10 Jul 2026 07:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Madison Avenue lifts Lakefront (NASDAQ: LKFT) ownership above 5% level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOWWJ3VzAzam1BeDl0dm5Xbnh4WDIzWWxlR09GVDdWbmpoU09WQ3ZBNFR5M2RvMHVIYlBTdHVDODAwN0JEYjJ3NFk2NmNMMTBPTTNlSkJYZ1IzTnpXYUV2VmJZOHZoSkNCV3A5cmZOdlRQU2ZHcFpFMktGMkpCS3luRWhNeWpnbHlPVFdNVDJYSlNZSjB5LWtNZk1wMTVnaXZUM1pWenFyemRBQ0pjR25SS0hKNEk5Z1J5a2lwdWRkaHlFZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Receives Transparency Notification from Madison Avenue Partners", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lakefront-receives-transparency-notification-madison-200100624.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T20:01:00+00:00", "published_display": "29 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUEhYMWZXel82M2ViVEpCT3lkTFpHUFJmMU56ZmI0bUhER1ZQX21obGZSc3dMVE4wdkRUSTJISktBZ1JIbGN1TE5LRGEwN2ZMRjF5WTJNbzNWOXVRbDYydXo4OUxBWmFQa3l4YjFGdGxwdThMQWZBTFRyTnd1VTlGM1JCcHdBOC03eTQ5ZTZEVl9lR2lKLUV2Q05DMW04b1R2TXotczF1TjlXQnlaVV9J?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics (ENXTAM:LKFT) Stock After Recent Gains Still A Recovery Opportunity?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOUTV2Xy1oVUI4S1M5ckxKcktULUg2QzFITHZCUVF3dnlfN0k3TzIxRl81cDZoUThMb3BhSXYzZHRNNDRubzBxVWpSbXVGMGpVd0pGM3A5Q0ZmMzJJNWp4b2k5elUwc2E3MUNmcFJVLWJBLVRfdVpNYVdFWmthQ21YLW9GcVR4bFY4YnRpMXZTaXZ6Rm5xUFZTTDhmNEo0WHJZcnEyX2lSRjVwcklW?oc=5", "source_name": "Market source", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics Launches 50 Million Euros Share Repurchase Program", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lakefront-biotherapeutics-launches-50-million-201816407.html", "source_name": "MT Newswires", "published_at": "2026-06-09T20:18:16+00:00", "published_display": "09 Jun 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Announces Initiation of \u20ac50 Million Stock Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOQ3c5UVZ2bzhFOVYwZlpSdVJUZ3RjMWJrZHFSY045X0ZUek1yNXh1LWxzcG9yYXdsX0lCc1h5bi0yd045MnNkTlJfaDR5THEweGZNeWdIckJ3clJsOE1MMkFjODBEVVNpT3dpR24yc3dXOWhyZ0JNUFc0Y0VmXzJFcG55WjJZVXpfTGE0YmZpbjY3eTFy?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics Names Eric Hedrick as Chief Medical Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lakefront-biotherapeutics-names-eric-hedrick-201939898.html", "source_name": "MT Newswires", "published_at": "2026-06-08T20:19:39+00:00", "published_display": "08 Jun 2026 20:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/lakefront-appoints-eric-hedrick-md-200100378.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T20:01:00+00:00", "published_display": "08 Jun 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gilead-sciences-gild-lakefront-biotherapeutics-043916213.html", "source_name": "Insider Monkey", "published_at": "2026-06-07T04:39:16+00:00", "published_display": "07 Jun 2026 04:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPaklHUjVLbE9BTFJkalhwcUdXMnY4aXk2c0d2dU1vSTNjbDlXRnJwYzVIcmxwazRjemxDUVNVQ2VJLWNDTU1haTFRMi1kbE5KSGV5QUFpSjJKbkZOSTlwU1JEOW13SFNTODYzVVJyNS1SSGlhbVlSOFNLc2VKM3dTUk9HVmwzbDZNTHN6dUxFMUhLWDRPS2szSUswcVBneXZm?oc=5", "source_name": "grafa.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Lakefront Complete Ouro Medicines Acquisition", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/gilead-sciences-lakefront-complete-ouro-204127804.html", "source_name": "MT Newswires", "published_at": "2026-06-04T20:41:27+00:00", "published_display": "04 Jun 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Receives Transparency Notification from Bank of America", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPRnhFbzZycGxWYl9GVGR2bUlmYTNOV3ZZYlptVnBtd3pQYTdkOTBJRUY1a3VWbHdWRUdkYW9JekVLaE9tQ3ZFOW9ReUYzZlRJU3ZHZGdVNU1uaWY4azFMcWZucmRHRFgzcnBrbUlZWnBYeXk4OGJmcW5MZzctWXo4S1pPRUVPal83RXZ3UkNXcUYzWEFNQWdRcEM3aGd1Nkd3UUhJbGE1MkxfTVc1QTlaSUtfdTc?oc=5", "source_name": "Market source", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Report: Lakefront Biotherapeutics NV Missed Revenue Estimates By 78%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9qdDdJT05vRTNrWVhnMmozbE5QajNMdGVFWTM5Y0wwNWVpWUt3VHRFSUxONmFRRE00X004eF95WEI5dmJmcXExc1V0RC14bExUUWZnV1pCNHpoQUJmcG1QN2F3NkczQQ?oc=5", "source_name": "MarketBeat", "published_at": "2026-05-10T05:12:57+00:00", "published_display": "10 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lakefront Biotherapeutics NV (AMS:LKFT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQUk1TGNXbHl3WEY1MF90VkVLRnE2anN2M3dNQzQ4V2JHRTlYTDlJaWpUUDZVSnVDYW1sTW04V2dVc3VfV25QbXZmdmlOd3NXdTEwelMxZDRCRENub3V6VXdxb1M3bGFPZVFPcHhkN2FNSzFLMGFQSjd0X2IzNU1SUDMtR0gxQkluUUpXSWdyVlZjRU9BenN0UDlpdEtPV1F1NU93YjI4eS0zdw?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LKFT Stock Price and Chart \u2014 NASDAQ:LKFT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1DV0pIQllMMTI0czlPUnBmMkRZV3EzZWxRcHZhcDdSRjl3dGhoSG55MmMxWjhfQWpXd1RtMHhNNTlxSGE3LTdTdlNkTVl3bHZrNDhyNFk3cHNjcTZJ?oc=5", "source_name": "TradingView", "published_at": "2026-05-08T11:48:31+00:00", "published_display": "08 May 2026 11:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQSW9mM3I5d1lnaHgzVDlPNFgzSVg3MFNNVmk0N0hLcGh3dko0MF9kWUVzS1phTmdDU1NjUGFZamZZWTBmdnFfanllME9NWmhxd0JiMjJzM3JCQU9SVnY0cEx3T3JnT1pDUlh3Vy0xR1lDem9hZ2ZqdUFXd2UzU1JRbkczUEdHZ1hSRGdTN1JfSHgtLUxQVTBJRjNGbS15Z05pZVd0a25wZl9OX0VjNnp4WHVVOUxxeUVwbTJ1TmdMTzZvcEZVbTkzSDdEUFhvZTdtZC1fb3R2SFZ4ZzQ?oc=5", "source_name": "StockStory", "published_at": "2026-07-15T07:00:00+00:00", "published_display": "15 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 71, "total_relevant": 31, "sentiment_summary": {"positive": 2, "negative": 3, "neutral": 26, "score": 49, "total": 31, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 5.36, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 30.27, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": 4.7, "twelve_week_move": 3.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.265548, "market_dynamics_buy_signal": false, "relative_strength": -18.219744, "fair_value_gap": -2.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.7597, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, +4.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "simplywall.st", "count": 4}, {"label": "MT Newswires", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "StockStory", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 22}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 12}, {"label": "Market update", "count": 12}, {"label": "Analyst action", "count": 3}, {"label": "Capital return", "count": 2}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "22", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.4% over one week, +4.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today"}], "updated_at": "2026-07-16T18:58:26.568363+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}